(Q39871971)

15 September 2017

title

Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones (English)

1 reference

15 September 2017

0 references

Zhi Dong Zhou

1

1 reference

15 September 2017

Tit Meng Lim

series ordinal

2

1 reference

15 September 2017

publication date

17 March 2009

1 reference

15 September 2017

published in

Free Radical Research

1 reference

15 September 2017

volume

43

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

417-430

1 reference

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Iron accelerates the conversion of dopamine-oxidized intermediates into melanin and provides protection in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Failure of the ubiquitin-proteasome system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Lewy bodies and parkinsonism in families with parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Dopamine induces proteasome inhibition in neural PC12 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Roles of glutathione (GSH) in dopamine (DA) oxidation studied by improved tandem HPLC plus ESI-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Dopamine auto-oxidation aggravates non-apoptotic cell death induced by over-expression of human A53T mutant alpha-synuclein in dopaminergic PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

Glutathione, iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760902801533

10.1080/10715760902801533

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference